Biodesix (BDSX) Enterprise Value (2019 - 2025)
Biodesix's Enterprise Value history spans 7 years, with the latest figure at -$19.0 million for Q4 2025.
- For Q4 2025, Enterprise Value rose 27.65% year-over-year to -$19.0 million; the TTM value through Dec 2025 reached -$19.0 million, up 27.65%, while the annual FY2025 figure was -$19.0 million, 27.65% up from the prior year.
- Enterprise Value reached -$19.0 million in Q4 2025 per BDSX's latest filing, down from -$16.6 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$11.5 million in Q1 2024 to a low of -$56.3 million in Q2 2021.
- Average Enterprise Value over 5 years is -$28.2 million, with a median of -$24.5 million recorded in 2022.
- Peak YoY movement for Enterprise Value: crashed 660.32% in 2021, then soared 70.36% in 2022.
- A 5-year view of Enterprise Value shows it stood at -$32.8 million in 2021, then plummeted by 31.32% to -$43.1 million in 2022, then surged by 39.0% to -$26.3 million in 2023, then increased by 0.15% to -$26.2 million in 2024, then increased by 27.65% to -$19.0 million in 2025.
- Per Business Quant, the three most recent readings for BDSX's Enterprise Value are -$19.0 million (Q4 2025), -$16.6 million (Q3 2025), and -$20.7 million (Q2 2025).